Dr. Martin Girard, MD, FRCPC
Claim this profileCentre Hospitalier de l'Université de Montréal (CHUM)
Studies Collapsed lung
Studies Pulmonary Atelectasis
5 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Martin Girard, MD, FRCPC is currently running
Tacrolimus
for Delayed Graft Function
The investigators hypothesize that preconditioning neurologically deceased organ donors with the calcineurin inhibitor tacrolimus will improve short and long-term transplant survival without causing harm. Organ donors will be randomized to receive either 0.02 mg/kg ideal body weight (IBW) of tacrolimus single infusion or placebo before organ recovery. All corresponding recipients are enrolled and data is collected up to 7 days post-transplant to determine graft function and at 1 year to collect outcomes of vital status, re-transplantation and dialysis. The CINERGY Pilot Trial assesses feasibility for the main trial.
Recruiting2 awards Phase 26 criteria
Open-Lung Extubation
for Collapsed Lung Prevention
Perioperative respiratory complications are a major source of morbidity and mortality. Postoperative atelectasis plays a central role in their development. Protective "open lung" mechanical ventilation aims to minimize the occurrence of atelectasis during the perioperative period. Randomized controlled studies have been performed comparing various "open lung" ventilation protocols, but these studies report varying and conflicting effects. The interpretation of these studies is complicated by the absence of imagery supporting the pulmonary impact associated with the use of different ventilation strategies. Imaging studies suggest that the gain in pulmonary gas content in "open lung" ventilation regimens disappears within minutes after the extubation. Thus, the potential benefits of open-lung ventilation appear to be lost if, at the time of extubation, no measures are used to keep the lungs well aerated. Recent expert recommendations on good mechanical ventilation practices in the operating room conclude that there is actually no quality study on extubation. Extubation is a very common practice for anesthesiologists as part of their daily clinical practice. It is therefore imperative to generate evidence on good clinical practice during anesthetic emergence in order to potentially identify an effective extubation strategy to reduce postoperative pulmonary complications.
Recruiting1 award N/A
More about Martin Girard, MD, FRCPC
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Martin Girard, MD, FRCPC has experience with
- Protective 'open-lung' Extubation
- Liberal Transfusion Strategy
- Restrictive Transfusion Strategy
- Placebo
- Tacrolimus
- Lung Ultrasound And Doppler
Breakdown of trials Martin Girard, MD, FRCPC has run
Collapsed lung
Pulmonary Atelectasis
Ventilator-Induced Lung Injury
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Martin Girard, MD, FRCPC specialize in?
Martin Girard, MD, FRCPC focuses on Collapsed lung and Pulmonary Atelectasis. In particular, much of their work with Collapsed lung has involved treating patients, or patients who are undergoing treatment.
Is Martin Girard, MD, FRCPC currently recruiting for clinical trials?
Yes, Martin Girard, MD, FRCPC is currently recruiting for 4 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Martin Girard, MD, FRCPC has studied deeply?
Yes, Martin Girard, MD, FRCPC has studied treatments such as Protective 'open-lung' extubation, Liberal transfusion strategy, Restrictive Transfusion Strategy.
What is the best way to schedule an appointment with Martin Girard, MD, FRCPC?
Apply for one of the trials that Martin Girard, MD, FRCPC is conducting.
What is the office address of Martin Girard, MD, FRCPC?
The office of Martin Girard, MD, FRCPC is located at: Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec H2X 3E4 Canada. This is the address for their practice at the Centre Hospitalier de l'Université de Montréal (CHUM).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.